Lactococcus lactis bacteraemia in a patient on probiotic supplementation therapy
| Autor: | Joseph M Garland, Thomas F. O'Brien, Amelia L. Gurley, Arkadiy Finn |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Antibiotic regimen law.invention Malaise 03 medical and health sciences Probiotic chemistry.chemical_compound 0302 clinical medicine law Internal medicine medicine Ingestion Blood culture 030212 general & internal medicine medicine.diagnostic_test biology business.industry Lactococcus lactis General Medicine Amoxicillin biology.organism_classification chemistry medicine.symptom business Ertapenem 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | BMJ Case Reports. 14:e243915 |
| ISSN: | 1757-790X |
| DOI: | 10.1136/bcr-2021-243915 |
| Popis: | A 59-year-old woman presented with fever and malaise and was found to have Lactococcus lactis bacteraemia. L. lactis infection is rare in humans with few reported cases, with most associated with dairy food product ingestion. The patient reported use of a multistrain over-the-counter probiotic supplement. After isolation of L. lactis from blood culture, the patient was treated empirically with ertapenem and amoxicillin and displayed clinical improvement. She remained well after completion of antibiotic regimen and discontinued probiotic supplementation use. We review the clinical presentation of L. lactis infection including diagnosis, identification and treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|